3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Mixed Dyslipidemia: new trials by email Literature Review of Mixed Dyslipidemia trials Research Report on Mixed Dyslipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Healthy Adult Volunteers AD-117 - Mixed Dyslipidemia, Food Effect Study of AD-117 | Phase 1 | Completed | Addpharma Inc. | 60 | 2026-02-10 | 2026-07-15 |
| Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers DW5124, DW5124-R - Mixed Dyslipidemia | Phase 1 | Completed | Daewon Pharmaceutical Co., Ltd. | 55 | 2025-05-08 | 2026-01-06 |
| Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab Evolocumab - Hyperlipidemia, Mixed Dyslipidemia | Phase 1 | Completed | Amgen | 18 | 2014-08-19 | 2022-11-07 |
Hyperlipidemias (1) · Kidney Failure, Chronic (1) · Renal Insufficiency (1)
Chronic Disease (1) · Disease Attributes (1) · Dyslipidemias (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Lipid Metabolism Disorders (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency, Chronic (1) · Urogenital Diseases (1) · Urologic Diseases (1)
evolocumab (1)
Addpharma Inc. (1) · Amgen (1) · Daewon Pharmaceutical Co., Ltd. (1)
South Korea (2) · United States (1)